Showing posts with label YSPSAH 永信东南亚 (7178). Show all posts
Showing posts with label YSPSAH 永信东南亚 (7178). Show all posts

Friday, September 9, 2011

拋風不停‧資金撤離‧外資心水股變票房毒藥


(吉隆坡7日訊)全球股市8月拋風刮不停,馬股也慘遭颱風尾掃到跌得灰頭土臉,“避風港”特質蕩然無存,外資受驚大舉撤離,令不少外資心水股身價大縮水,成為股市“票房毒藥”。

亞航15.52%跌幅最深

以外資持股最高的數隻股項計算,其中亞洲航空(AIRASIA, 5099, 主板貿服組)跌幅最深,全月下跌15.52%或61仙,從7月29日的3令吉93仙回退至8月杪的3令吉32仙;聯昌集團(CIMB, 1023, 主板金融組)跌幅也不輕,單月下挫14.51%或1令吉20仙。

楊忠禮電力表現勝綜指

另外,雲頂(GENTING, 3182, 主板貿服組)、怡保工程(IJM, 3336, 主板建筑組)和亞通(AXIATA, 6888, 主板貿服組)跌幅介於7.45%至12.94%,跌幅明顯高於富時綜指的6.56%。

相比之下,外資持股比重相對較低的楊忠禮電力(YTLPOWR, 6742, 主板基建計劃組),股價從7月29日的1令吉96仙跌至8月杪的1令吉88仙,單月下跌8仙或4.08%,表現明顯超越富時綜指。

馬航(MAS, 3786, 主板貿服組)次季雖錄得巨虧,但在亞航換股計劃支撐下,全月逆市上漲6仙或4.05%,從7月杪的1令吉48仙增至1令吉54仙,合順(UMW, 4588, 主板消費品組)和建裕珍廠(KIANJOO, 3522, 主板工業產品組)則分別跌2.03%和3.86%。

權重股影響首當其衝

分析員認為,內外經濟形勢驟變,對國內經濟影響不明朗,加上馬股估值過於昂貴,導致外資開始轉買為賣,權重股影響首當其衝。

“隨著全球經濟轉疲,歐洲主權債務危機越演越烈,全球資金可能遷移至更具投資潛能的市場,而馬股估值偏高,外資可能陸續從馬股撤資,流向估值相對廉宜的市場。”

聯昌研究報告顯示,馬股今年盈利增幅僅5%,但14.9倍本益比估值與印尼股市名列區域最高,而2012年則以12.9倍本益比水平冠絕區域同儕,估值明顯過高。

宜避開估值過高外資股

有鑑於此,達證券建議,投資者宜避開估值過高的外資持股比重股項,但放眼累積估值遭低估,但卻擁有良好基本面,和足以緩慢復甦週期成長的商業模式的股項。

馬銀行研究指出,歐元區和美國疑慮未解,預期市場可能持續動盪,但強勁國內因素將為大盤帶來支撐,建議投資者採取防禦政策,並繼續持有專注國內建築和油氣類股,而通訊、博彩和產業投資信託將提供穩定盈利和週息率表現。

外資淨賣38億
馬股存走低風險

馬股8月直跌至3年內低谷,外資在5個月來成為“淨賣家”,沽出38億令吉股票,分析員認為儘管外資在9月初開始回流,但情況是否受到控制仍難以判斷,馬股未來仍潛存走低風險。

馬銀行研究分析員黃秋嫻說,馬股在8月猛挫101.5點,其中外資淨賣38億令吉,但當月外資淨流出相等於4月至7月淨買入的58%,因此馬股仍潛存走低風險。

根據大馬交易所網站,接連4個月外資淨流入後,這次是今年內最大資金流出,但自2010年下半年開始扮演淨賣家角色的本地基金,卻在8月崛起成為淨買家,從8月5日起淨買進28億7千560萬令吉,而散戶也買進9千零20萬令吉。

小資本股難逃一劫

但富時小資本指數8月下挫9.42%,跌幅明顯高於富時綜指和富時全股項指數的6.56%和7.25%,顯示散戶投資者也隨外資大舉離場。

分析員指出,小資本股在危機浮現時,常遭投資者拋售來平衡投資組合,隨著散戶投資情緒傾向謹慎,以散戶為主要投資對象的小資本股自然難逃一劫。


(星洲日報/財經)

Wednesday, August 17, 2011

YSPSAH Volume Distribution

                            1 Day

                            5 Day
                            5 days chart excludes current trading day's data


                            10 Day
                            10 days chart excludes current trading day's data

Saturday, August 13, 2011

YSPSAH Historical Charts

Weekly Price Chart


30 Day Chart


2 Weeks Historical Intraday Chart


6 Month Chart


6 Months Historical Daily With Technical Indicators


6 Months Historical Candlesticks With Technical Indicators


1-Year Historical Daily Chart


1 Year Historical Daily With Technical Indicators


5-Year Historical Daily Chart

YSPSAH Announcements



CURRENT



CHANGES IN SHAREHOLDING

ANNUAL REPORTS




HISTORICAL



CHANGES IN SHAREHOLDING





ARCHIVES



CHANGES IN SHAREHOLDING




Changes In Shareholder

YSPSAH Price









YSPSAH 永信东南亚 (7178)







Y.S.P. SOUTHEAST ASIA HOLDING BERHAD
16th Floor, Plaza VADS,
No.1, Jalan Tun Mohd. Fuad,
Taman Tun Dr. Ismail,
60000 Kuala Lumpur

Tel: +603-7727 6390 (12 Lines)
Fax: +603-7727 6701
Email: info@yspsah.com

Listing Date: 12.01.2004
Par Value: 1.00
IPO Price: 1.43

Market: MAIN
Sector: CONSUMER
Major Industry: PHARMACEUTICALS

Y.S.P. SOUTHEAST ASIA HOLDING BERHAD is a Malaysia-based company engaged in investment holding and provision of management services. Through its subsidiaries, Y.S.P.SAH operates in three segments: pharmaceutical trading, which is engaged in the import, export and trading in various kinds of pharmaceutical products; pharmaceutical manufacturing, which is engaged in the manufacturing of pharmaceutical products, and other operations, which is engaged in investment holding. During the year ended December 31, 2009, Y.S.P.SAH registered a total of 27 new products, of which 16 are manufactured in-house and the remaining 11 imported from its principal and overseas partners. On February 5, 2009, the Company incorporated a subsidiary with a 60% equity interest under the name of Sun Ten Southeast Asia Holding Pte. Ltd.

Since its establishment has grown to become one of the innovative and leading pharmaceutical companies in Malaysia. The Group became more competent and hence, in 2004 it gained successful listing on the Bursa Malaysia Securities Bhd ( Kuala Lumpur Stock Exchange ) and later transferred to the Main Board, which marked a major milestone in history. Today the Group boasts a wide array of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products, with regional offices as well as strategic alliances in Singapore, Vietnam, Philippine, Myanmar, Cambodia, Thailand, Indonesia, Brunei, Laos , as well as Sri Lanka, Africa and countries in Middle East.

In addition, have also diversified into traditional herbal products with Sun Ten Pharmaceutical Co. Ltd, a renowned GMP manufacturer of standardized and concentrated herbal extracts from Taiwan R.O.C.
Related Posts Plugin for WordPress, Blogger...